We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+35.97%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$343M
Cap. Flow
+$210M
Cap. Flow %
19.51%
Top 10 Hldgs %
30.46%
Holding
99
New
30
Increased
28
Reduced
17
Closed
19

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$29M
2
INSM icon
Insmed
INSM
+$26.6M
3
HUM icon
Humana
HUM
+$22.7M
4
CYTK icon
Cytokinetics
CYTK
+$19.3M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$15.7M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$19.9M
2
TFX icon
Teleflex
TFX
+$17.5M
3
NTRA icon
Natera
NTRA
+$13.2M
4
ZBH icon
Zimmer Biomet
ZBH
+$12.2M
5
LLY icon
Eli Lilly
LLY
+$11.4M

Sector Composition

Rank Sector Weight
1 Healthcare 94.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
76
Guardant Health
GH
$22.1B
$3.09M 0.29%
+150,000
New +$3.22M
APGE icon
77
Apogee Therapeutics
APGE
$10.2B
$2.66M 0.25%
+40,000
New +$1.75M
KROS icon
78
Keros Therapeutics
KROS
$212M
$2.65M 0.25%
+40,000
New +$2.37M
AXSM icon
79
Axsome Therapeutics
AXSM
$11.4B
$2.39M 0.22%
+30,000
New +$2.52M
FATE icon
80
Fate Therapeutics
FATE
$318M
$1.47M 0.14%
200,000
-700,000
-78% -$4.33M
ACAD icon
81
Acadia Pharmaceuticals
ACAD
$5.06B
– –
-130,000
Closed -$4.07M
AGL icon
82
Agilon Health
AGL
$1.5B
– –
-13,000
Closed -$4.08M
ARVN icon
83
Arvinas
ARVN
$579M
– –
-175,000
Closed -$7.2M
CNC icon
84
Centene
CNC
$32.8B
– –
-130,000
Closed -$9.65M
CYTK icon
85
CALL
Cytokinetics
CYTK
$10.6B
– –
-400,000
Closed -$33.4M
CYTK icon
86
PUT
Cytokinetics
CYTK
$10.6B
– –
-100,000
Closed -$8.35M
HOLX
87
DELISTED
Hologic
HOLX
– –
-100,000
Closed -$7.14M
ILMN icon
88
Illumina
ILMN
$28.7B
– –
-51,400
Closed -$6.96M
MDT icon
89
Medtronic
MDT
$114B
– –
-120,000
Closed -$9.89M
OGN icon
90
Organon & Co
OGN
$3.59B
– –
-150,000
Closed -$2.16M
SIBN icon
91
SI-BONE Inc
SIBN
$838M
– –
-315,000
Closed -$6.61M
SNY icon
92
Sanofi
SNY
$104B
– –
-400,000
Closed -$19.9M
TDOC icon
93
Teladoc Health
TDOC
$1.2B
– –
-100,000
Closed -$2.15M
TFX icon
94
Teleflex
TFX
$5.88B
– –
-70,000
Closed -$17.5M
VTYX
95
DELISTED
Ventyx Biosciences
VTYX
– –
-500,000
Closed -$1.24M
ZBH icon
96
Zimmer Biomet
ZBH
$18.2B
– –
-100,000
Closed -$12.2M
ZNTL icon
97
Zentalis Pharmaceuticals
ZNTL
$297M
– –
-250,000
Closed -$3.79M
PDCO
98
DELISTED
Patterson Companies, Inc.
PDCO
– –
-100,000
Closed -$2.85M
RVNC
99
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-450,000
Closed -$3.96M
1 2 3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Integral Health Asset Management held 99 positions worth $1.08B, up 47% from $734M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Integral Health Asset Management deployed $210M of net new capital in Q1 2024, opening 30 new positions and adding to 28 existing holdings. Its largest new stake was Merck: 235,000 shares worth $31M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 94% a quarter earlier.

On the sell side, the largest reduction was Natera, an estimated $13.2M trimmed.

  • Integral Health Asset Management's largest Q1 2024 buy was Merck: 235,000 shares worth $31M.
  • Integral Health Asset Management added most to Insmed in Q1 2024, an estimated $26.6M increase.
  • Integral Health Asset Management's biggest Q1 2024 reduction was Natera, cutting an estimated $13.2M.
  • Integral Health Asset Management fully exited Sanofi in Q1 2024, selling an estimated $19.9M.
  • Integral Health Asset Management's ten largest holdings make up 30% of its $1.08B portfolio in Q1 2024.
  • Integral Health Asset Management opened 30 new positions and closed 19 in Q1 2024.
  • Integral Health Asset Management's portfolio value rose 47% quarter-over-quarter to $1.08B.

Based on Integral Health Asset Management's 13F filing for Q1 2024, filed 15 May 2024.